Right, thought it was Penn. 5% may actually be too
Post# of 72436
"In partial consideration of the license, Licensee shall pay to Penn a royalty of 1) 3.0% on gross sales of a pharmaceutical product, 2) 1.5% of gross-sales of a medical devise or other products approved by a 510(k) regulatory filing or 3) 0.5% on all other gross sales for Penn Licensed Products sold by Licensee, its Affiliates and/or its Sublicensees. "
Where did you see 5%?
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)